EU
Keeping tabs on pharma: Tensions rise between AstraZeneca and EU over vaccine delays and R&D innovation challenge developed to improve healthcare opportunities
January 29 by Emily UwemedimoAstraZeneca's vaccine is currently in the final stages of the approval process with the European Medicines Agency, but there are problems with supply and delivery
Keeping tabs on Covid-19: Moderna eliminates its IP barriers for vaccine development and Israeli manufacturing facility committed to support supply of EU vaccines
October 09 by Emily UwemedimoDiscover the latest solutions on offer from Moderna and Mapi Pharma to support the global efforts to provide Covid-19 vaccinations
Doubts over ‘No Deal’ rise: How Pharma is preparing for Brexit
January 22 by Pharmaceuticals & Biotechnology EditorFollowing the majority rejection of a proposed withdrawal agreement, the pharmaceutical industry is left to prepare for a 'no deal' scenario
Will a "no-deal" Brexit lead to drug shortages?
July 31 by Adam MusprattA “no-deal” may result in drug shortages across the UK. Find out what drugs will be affected the most, how severe shortages will be and more.
EU Clinical trial Regulation: Producing plain language summaries
June 15 by Pooja PhogatProducing simplified overviews of clinical studies for the general public isn’t as straightforward a proposition as it might seem.
EMA Policy 0070: 5 ways to balance patient privacy with better data utility
April 16 by Pooja PhogatPooja Phogat, regulation and compliance expert at Kinapse, provides insight on the most effective approaches that reflect the spirit of the Policy
Pharma & Biotech News Highlights Q3 2016
October 18 by Pharma IQ NewsFollowing a quarter that featured reports stating that Novartis had dramatically redistributed its cell and gene therapy unit 1 and saw the public focus turn once again to drug price hikes, Pharma IQ...
The Ascent of Precision Medicines
May 17 by Pharmaceuticals & Biotechnology EditorTraditionally the pharma industry has lent towards the view of a one-size fits all approach to the application of therapeutics. Now, eyes are set firmly on the notion of personalised medicine – therap...
Are You Cosmetic Compliance Ready?
July 28 by Pharmaceuticals & Biotechnology EditorWith very limited opportunities for pre-market approval, only mainly in-market control inspections, cosmetic companies from all over the globe must employ rigid compliance awareness to ensure...
Top 10 European Cosmetic Compliance Hurdles
July 21 by Pharmaceuticals & Biotechnology EditorAccording to BCC Research, the total global cosmetic and toiletry ingredients market value is expected to reach $24.5 billion in 2018 after increasing at a five year (CAGR) of 4.6%. [inlinead] F...
Pharmaceutical Serialisation - The Global Problem with No Global Solution
August 12 by Andrea CharlesSerialisation is a global problem and the different regional requirements are challenging. In this Pharma IQ interview Pasi Kemppainen, executive consultant for serialisation and traceability and cu...
Blue Pill Pirates: How Regulators and Industry are Working to Reduce Online Fraud
May 23 by Gerald ClarkeAnyone with an email account is likely to be unfortunate enough to have received an email promising male sexual enhancement pills online for low prices. Likely they are full of spelling mistakes and...